IP Library Granted Patent US 10,016,561
Granted Patent B2
US 10,016,561 · App. 13/842,005 · Granted Jul 10, 2018

Clinical variable determination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,016,561
App. No.
13/842,005
Granted
Jul 10, 2018
Kind
B2
Abstract

A computer implemented method of determining a clinical variables utilizing an insulin pump that includes initiating blood glucose measurements, initiating ingestion of carbohydrates and receiving input data based on the blood glucose measurements and the ingestion of carbohydrates and utilizing the data to calculate clinical variables. The invention may include presenting instructions to a patient to take various actions and to input various data. The clinical variables determined may be stored in memory and then used to calculate insulin doses and to send a signal to an insulin pump to infuse the insulin dose calculated.

Claims (28)

1. An ambulatory infusion pump for infusing insulin into a living being, the pump having a controller, the controller being programmed with an algorithm that executes the following:

receiving input data related to a first blood glucose measurement;

presenting instructions to a user to ingest a quantity of carbohydrates;

receiving an input from the user indicating the quantity of carbohydrates ingested;

receiving input data related to a second blood glucose measurement at a time after the input indicating the quantity of carbohydrates ingested;

calculating a change in blood glucose between the first blood glucose measurement and the second blood glucose measurement;

calculating a carbohydrate factor by dividing the change in blood glucose by the quantity of carbohydrates ingested;

saving the carbohydrate factor in memory;

receiving input from the user as to a quantity of carbohydrates to be ingested at a subsequent meal after saving the carbohydrate factor into memory;

utilizing the carbohydrate factor in memory to calculate an insulin dose to be infused prior to the meal; and

causing the pump to infuse the insulin dose,

wherein the time of the second blood glucose measurement is determined based on an identification of a peak of a postprandial rise in blood glucose based on input from a continuous glucose monitoring system.

2. The automated ambulatory infusion pump as claimed in claim 1 , wherein the algorithm further executes: receiving the input data related to the first blood glucose measurement or the second blood glucose measurement from the continuous glucose monitoring system.

3. The automated ambulatory infusion pump as claimed in claim 1 , wherein the algorithm further executes: presenting instructions to the user to initiate the first blood glucose measurement or presenting instructions to the user to initiate the second blood glucose measurement.

4. An ambulatory infusion pump for infusing insulin into a living being, the pump having a controller, the controller being programmed with an algorithm that executes the following:

receiving input data related to a first blood glucose measurement;

presenting instructions to a user to ingest a quantity of carbohydrates;

receiving an input from the user indicating the quantity of carbohydrates ingested;

receiving input data related to a second blood glucose measurement at a time after the input indicating the quantity of carbohydrates ingested;

calculating a change in blood glucose between the first blood glucose measurement and the second blood glucose measurement;

calculating a carbohydrate factor by dividing the change in blood glucose by the quantity of carbohydrates ingested;

saving the carbohydrate factor in memory;

receiving input from the user as to a quantity of carbohydrates to be ingested at a subsequent meal after saving the carbohydrate factor into memory;

utilizing the carbohydrate factor in memory to calculate an insulin dose to be infused prior to the meal; and

causing the pump to infuse the insulin dose,

wherein the time of the second blood glucose measurement is determined based on an identification of when blood glucose level has stabilized after a postprandial rise in blood glucose based on input from a continuous glucose monitoring system.

5. The automated ambulatory infusion pump as claimed in claim 4 , wherein the algorithm further executes: receiving the input data related to the first blood glucose measurement or the second blood glucose measurement from the continuous glucose monitoring system.

6. The automated ambulatory infusion pump as claimed in claim 4 , wherein the algorithm further executes: presenting instructions to the user to initiate the first blood glucose measurement or presenting instructions to the user to initiate the second blood glucose measurement.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: SAINT, SEAN; ROSINKO, MICHAEL
To: TANDEM DIABETES CARE, INC.
Reel/Frame 030687/0213 →